Gardenin A treatment attenuates inflammatory markers, synuclein pathology and deficits in tyrosine hydroxylase expression and improves cognitive and motor function in A53T-α-syn mice.

MLA

Hack, Wyatt, et al. “Gardenin A Treatment Attenuates Inflammatory Markers, Synuclein Pathology and Deficits in Tyrosine Hydroxylase Expression and Improves Cognitive and Motor Function in A53T-α-Syn Mice.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 173, Apr. 2024, p. 116370. EBSCOhost, https://doi.org/10.1016/j.biopha.2024.116370.

APA

Hack, W., Gladen-Kolarsky, N., Chatterjee, S., Liang, Q., Maitra, U., Ciesla, L., & Gray, N. E. (2024). Gardenin A treatment attenuates inflammatory markers, synuclein pathology and deficits in tyrosine hydroxylase expression and improves cognitive and motor function in A53T-α-syn mice. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 173, 116370. https://doi.org/10.1016/j.biopha.2024.116370

Chicago

Hack, Wyatt, Noah Gladen-Kolarsky, Swarnali Chatterjee, Qiaoli Liang, Urmila Maitra, Lukasz Ciesla, and Nora E Gray. 2024. “Gardenin A Treatment Attenuates Inflammatory Markers, Synuclein Pathology and Deficits in Tyrosine Hydroxylase Expression and Improves Cognitive and Motor Function in A53T-α-Syn Mice.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 173 (April): 116370. doi:10.1016/j.biopha.2024.116370.